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Abstract
Background: Glycosphingolipids (GSL) are integral components of mammalian cell membranes
that are involved in cell adhesion and cell signaling processes. GSL are subdivided into structural
series, like ganglio-, lacto/neolacto-, globo- and isoglo-series, which are defined by distinct
trisaccharide cores. The β1,3 N-acetylglucosaminyltransferase-V (B3gnt5) enzyme catalyzes the
formation of the Lc3 structure, which is the core of lactoseries derived GSL.
Results: The biological significance of the glycoconjugates produced by the B3gnt5 enzyme was
investigated by inactivating the B3gnt5 gene in the mouse germline. The disruption of the B3gnt5
protein-coding region in mouse embryonic stem cells resulted in reduced Lc3-synthase activity,
supporting its specific contribution to lactoseries derived GSL synthesis. Breeding of heterozygous
mutant mice failed to produce any viable progeny homozygous for the B3gnt5-null allele. The
genotypic examination of embryos from heterozygous crosses showed that the disruption of the
B3gnt5 gene leads to pre-implantation lethality. This finding was compatible with the expression
pattern of the B3gnt5 gene in the pre-implantation embryo as shown by in situ hybridization. The
analysis of GSL profiles in embryonic stem cells heterozygous for the B3gnt5-null allele confirmed
the reduced levels of lactoseries derived GSL levels and of other GSL species.
Conclusion: The disruption of the B3gnt5 gene in mice affected the expression of lactoseries
derived GLS and possibly of protein-bound β3GlcNAc-linked glycans, thereby demonstrating an
essential contribution of these glycoconjugates in early embryonic development, and supporting the
importance of these glycoconjugates in cell differentiation and adhesion processes.
Background
Glycosphingolipids (GSL) represent a large family of gly-
coconjugates, which are found abundantly on cellular
membranes. GSL are classified into different series
defined by their respective core structures. In vertebrates,
the main GSL series are called ganglio-, lacto-, globo-,
isoglobo-, and muco-series [1]. The functional signifi-
cance of GSL is diverse since these glycoconjugates have
been implicated in processes such as cell adhesion, cell
migration, regulation of signaling proteins and binding of
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pathogens and toxins [2,3]. The repertoire of GSL
expressed by an organism is subject to changes according
to cell type and developmental stage. Consequently, sev-
eral stem cell and differentiation markers of early embry-
onic development, such as the stage-specific embryonic
antigens SSEA-1, -3 and -4, represent carbohydrate
epitopes carried by GSL [4-6].
The diversity of GSL is shaped by the action of multiple
glycosyltransferase enzymes localized in the Golgi appara-
tus. The inactivation of key glycosyltransferase genes
allows investigation of the functional specificity of indi-
vidual GSL structures or of a whole GSL series. The β1,3 N-
acetylglucosaminyltransferase-V (B3gnt5) enzyme initi-
ates the formation of the lactoseries GSL by transferring
GlcNAc in a β1,3-linkage to lactosylceramide. This trans-
fer event leads to the synthesis of the Lc3 structure (Fig. 1)
[7,8]. The B3gnt5 gene is expressed during mouse devel-
opment and then again later mainly in the spleen and pla-
centa in adult mice. Additionally B3gnt5 transcripts are
found in the adult mouse brain where B3gnt5 expression
is limited to cerebellar Purkinje cells [7].
The B3gnt5 enzyme has been shown to be key in the
expression of sulfoglucuronylglycolipids (SGGL) in the
developing nervous system [9]. SGGL are expressed in a
regulated manner during embryonic brain development
and again postnatally [10-13]. For example, SGGL carry
the HNK-1 epitope, which has been implicated in the reg-
ulation of synaptic plasticity [14,15]. In addition, the
developmentally regulated expression of SGGL coincides
with certain cell migration and differentiation phases
[16].
The B3gnt5 enzyme also initiates the formation of the
SSEA-1 epitope, which is identical to the Lewis X antigen.
SSEA-1 corresponds to the trisaccharide
Galβ1,4(Fucα1,3)GlcNAc which is first found on 8-cell
stage embryos and in mouse embryonic stem (ES) cells
[17]. The SSEA-1 epitope, which is mainly found on lacto-
series derived GSL, is believed to participate in the regula-
tion of cell adhesion during embryogenesis, cell
differentiation, and development of the neuronal system
[4,18]. In order to study the developmental and physio-
logical processes mediated by lactoseries derived GSL, we
have inactivated the B3gnt5 gene in mice by homologous
recombination in ES cells. This mouse model suggests an
essential contribution of the lactoseries derived GSL series
in the very early stages of mouse development.
Results
To address the functional role of the B3gnt5  gene in
mouse development and physiology, we inactivated this
gene by homologous recombination in mouse ES cells.
The B3gnt5 targeting vector (Fig. 2A) was electroporated
into R1 and TC1 ES cells. After selection with G418 and
screening of 300 cell clones, we identified four ES cell
clones bearing the homologous recombined allele. The
homologous recombination at the B3gnt5 locus was con-
firmed using both PCR and genomic Southern blot analy-
sis. The genomic Southern probe distinguished between
the wildtype and the null allele by producing diagnostic
EcoRI fragments of 3 kbp and 2.3 kbp, respectively (Fig.
2B). The absence of chromosomal aberrations was veri-
fied by karyotyping the four homologously recombined
ES cells (data not shown).
The inactivation of the B3gnt5  gene was confirmed by
measuring the level of N-acetylglucosaminyltransferase
activity in targeted ES cells. The enzymatic activity towards
the artificial acceptor Gal(β1-0)p-nitrophenol and
towards lactosylceramide was assayed in wildtype and in
B3gnt5-targeted ES cells. The transfer of GlcNAc to Gal(β1-
0)p-nitrophenol was reduced in R1 and in TC1 B3gnt5-
Biosynthesis of GSL core structures Figure 1
Biosynthesis of GSL core structures. GSL biosynthesis is 
initiated by the transfer of Glc to ceramide (Cer) catalyzed 
by the Ugcg enzyme. After addition of β1,4-linked Gal by 
Lac-Cer synthase, distinct core structures are defined by the 
action of different glycosyltransferases. The B3gnt5 enzyme 
catalyzes the Lc3 structure, which is the core of lactoseries 
GSL. The elongation of Lc3 by a α1,3-fucosyltransferase and 
a β1,4-galactosyltransferase yields the SSEA-1 antigen. l, Glc; 
m, Gal; n, GlcNAc; r Sia; s, Fuc.
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B3gnt5 gene targeting in ES cells Figure 2
B3gnt5 gene targeting in ES cells. A. The targeting vector was produced by cloning a neo resistance cassette into exon 4 of 
the mouse B3gnt5 gene. The construct was flanked by two genomic arms of 1.7 and 3.6 kbp. A genomic probe located just out-
side of the targeted region was used to detect homologous recombination. B. Genomic Southern blotting of ES cell clones. 
Genomic DNA of wildtype (WT) ES cells and of two ES cell clones bearing a homologously recombined B3gnt5 allele (5B5 and 
M20) were digested with EcoRI and hybridized to the genomic probe. C. Genotyping of wildtype (+) and targeted (-) B3gnt5 
alleles by PCR as described in the Materials and Methods section.
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targeted ES cells, but did not reached 50% of the activity
measured in wildtype cells (Fig. 3). When using lactosyl-
ceramide, the physiological acceptor of the B3gnt5
enzyme, the N-acetylglucosaminyltransferase activity
detected in the targeted ES cells was indeed reduced to
50% of the normal levels this demonstrating the loss of a
functional B3gnt5 allele.
The four ES cell clones bearing the B3gnt5-null allele were
injected into C57BL/6 blastocysts to produce chimeric off-
spring. Two male chimeric founders were obtained from
the blastocysts microinjected with the two R1 ES cell
clones, whereas the microinjection of TC1 ES cells did not
yield any viable offspring. The chimeric males were mated
with wildtype C57BL/6 females and the F1 progeny
screened with PCR for germ line transmission of the dis-
rupted allele. Both chimeric males transmitted the null
allele to their progeny. Offspring positive for the dis-
rupted gene were backcrossed onto the C57BL/6 back-
ground for five generations. All the heterozygous
offspring obtained from the chimeric males were grossly
normal. Both male and females carriers of the null allele
were obtained. Heterozygote mice were then bred to pro-
duce homozygous-null offspring. After crossing 17 inde-
pendent heterozygote breeding pairs, no homozygous-
null offspring were detected (Table 1). The ratio of
wildtype to heterozygous-null mice was 34% to 66%, thus
corresponding to a Mendelian allele distribution assum-
ing a complete lethality of homozygous-null offspring.
Since the expression of the B3gnt5 gene was shown to be
elevated in embryos by mid-gestation [7], we genotyped
69 embryos isolated at E10 to assess whether
homozygous-null embryos could be detected. The size
and morphology of the embryos isolated at that stage
were normal (data not shown) and the genotypic analysis
demonstrated that 29.1% and 70.9% of embryos were
wildtype and heterozygous-null, respectively (Table 1).
Notably, no sites of resorption were observed in the uteri
examined at mid-gestation. To identify whether the lack
of embryonic development in B3gnt5-null mice was
related to an implantation defect, we setup time-matings
of heterozygous-null mice and examined the genotype of
resulting embryos at the blastocyst stage. Again, no
homozygous-null embryos were detected (Table 1),
thereby indicating that the B3gnt5 gene is required for
blastocyst development.
Since no homozygous-null embryos could be recovered,
we analyzed the expression pattern of B3gnt5  in pre-
implantation embryos to confirm that the gene was
indeed expressed during early embryogenesis. In situ
hybridization showed the presence of the B3gnt5 tran-
script already at the 2-cell stage. The expression was uni-
form in all embryonic stages up to the morula stage. In
blastocysts, B3gnt5 expression was confined to the inner
cell mass, as no signal was observed in trophoblast cells
(Fig. 4). The expression of the B3gnt5 gene throughout
early embryogenesis was compatible with the finding of a
pre-implantation lethality in B3gnt5-null mice.
The inner cell mass of blastocysts is the source of ES cells
used for gene targeting. Accordingly, we examined the
level of B3gnt5 gene expression in the R1 and TC1 ES cells
by quantitative PCR. The B3gnt5 mRNA levels were iden-
tical in the two cell lines and comparable to the expression
of the housekeeping Polr2a  polymerase gene (data not
shown). Because the B3gnt5 enzyme is involved in the
biosynthesis of the lactoseries derived GSL, we also ana-
lyzed GSL profiles quantitatively in wildtype and in
B3gnt5-targeted R1 and TC1 ES cells. GSL were isolated
from ES cells by organic solvent extraction and digested by
ceramide glycanase to release the carbohydrate moiety.
The resulting oligosaccharides were labeled with 2-ami-
nobenzamide at their reducing end and separated by
HPLC [19]. The comparison between wildtype and
B3gnt5-targeted ES cells showed decreased amounts of
several GSL structures (Fig. 5A). The lactoseries GSL Lc3,
the product of the B3gnt5 enzyme, was not detected in ES
cells. However, its elongation products, the lactoseries
derived Lc5 and Lc6 were identified and found to be
present at lower levels in B3gnt5-targeted ES cells. The
decreased amounts of GSL found in B3gnt5-targeted ES
cells were not limited to lacto-series GSL, since the gan-
N-acetylglucosaminyltransferase activity in ES cells Figure 3
N-acetylglucosaminyltransferase activity in ES cells. 
ES cells of the R1 and TC1 lines were lysed and N-acetylglu-
cosaminyltransferase (GlcNAcT) activity was measured 
towards the acceptor substrates Gal(β-0)p-nitrophenol 
(pNP) and lactosylceramide (Lac-Cer). Black bars show Glc-
NAcT activity of wildtype ES cells and open bars show GlcN-
AcT activity of B3gnt5-targeted ES cells. Each value 
represents the average + S.D. of three independent measure-
ments.
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gliosides GM3, GM1, GD1 and the globosides Gb3, Gb5
were also reduced. The identity of the oligosaccharide
structures detected by HPLC was confirmed by mass-spec-
trometry. The oligosaccharide sequences were further
examined by fragmentation analysis (Fig. 5B). This analy-
sis of GSL profiles on ES cells demonstrated the contribu-
tion of the B3gnt5 enzyme to the formation of lactoseries
derived GSL.
Discussion
By disrupting the B3gnt5 gene, we aimed to improve cur-
rent appreciation of the functions of lactoseries derived
GSL in vivo. Our study suggests an essential role of this
GSL series in pre-implantation embryonic development
by showing that B3gnt5-null blastocysts could not be
retrieved from heterozygous matings. The expression of
the B3gnt5 gene from the two-cell stage up to the blasto-
cyst stage would suggest a role for lactoseries derived GSL
in cell-cell adhesion, possibly contributing to embryo
compaction and implantation. Similarly, the SSEA-1 anti-
gen has been shown to mediate the tight adhesion of blas-
tomeres, since the addition of multivalent SSEA-1
structures promotes embryo decompaction [20]. The for-
mation of the SSEA-1 antigen requires the action of the
α1,3 fucosyltransferase FUT9 [21]. The disruption of the
Fut9 gene in mice abolished the formation of the SSEA-1
antigen in pre-implantation embryos, but this loss did not
affect the compaction and implantation processes [18].
This finding showed that the fucose residue is critical for
marking the antigen but that fucose is dispensable for the
potential adhesion properties of the lactoseries derived
structure.
The early lethality observed in the B3gnt5 gene disruption
model contrasts with the phenotype described for mice
lacking the ceramide glucosyltransferase Ugcg gene, which
initiates GSL biosynthesis (Fig. 1). Ugcg homozygous-null
embryos have been reported to die between embryonic
days E7.5 and E9.5 [22]. Since Ugcg activity is required for
the formation of lactoseries derived GSL, the reverse order
would be expected for the onset of lethality in the Ugcg
and B3gnt5 gene disruptions. A similar paradoxical situa-
tion was observed in the globoside GSL pathway when
comparing the phenotypes resulting from the disruptions
of the α1,4 galactosyltransferase Gb3-synthase [23] and
β1,3 N-acetylgalactosaminyltransferase Gb4-synthase
[24] genes. Mice lacking the Gb3-synthase gene developed
normally and did not show any physiological abnormal-
Table 1: Genotype analysis of B3gnt5 heterozygous crosses at various stages of murine development
Developmental Stage WT (+/+) Het (+/-) KO (-/-) Total screened
Blastocyst (E3.5) 20.8% 79.2% 0 48
Embryo (E10) 29.1% 70.9% 0 69
Viable pups 34% 66% 0 205
B3gnt5 expression in pre-implantation embryos Figure 4
B3gnt5 expression in pre-implantation embryos. All pre-implantation stages investigated show the uniform presence of 
B3gnt5 transcripts up to the morula stage. B3gnt5 transcripts were confined to the inner cell mass at the blastocyst stage. 
Sense and antisense RNA probes were DIG-labeled as described in the Materials and Methods section. The pictures show 
embryos taken from C57Bl/6 wildtype matings.
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Glycolipid analysis in ES cells Figure 5
Glycolipid analysis in ES cells. A. The oligosaccharide moiety of ES cell GSL was cleaved by ceramide glycanase, labeled 
with 2-aminobenzamide and separated by normal phase HPLC. The retention times of glucose units (GU) is indicated on the x-
axis. The dotted line shows the GSL profile of wildtype R1 ES cells and the plain line shows the GSL profile of the R1 clone 
5B5. B. Mass spectrometric fragmentation spectrum of the Lc6 oligosaccharide obtained from the corresponding HPLC frac-
tion. The main fragment ions are labeled and their assignment to the Lc6 structure is depicted.BMC Developmental Biology 2008, 8:109 http://www.biomedcentral.com/1471-213X/8/109
Page 7 of 10
(page number not for citation purposes)
ity [25]. By contrast, the disruption of the Gb4-synthase
gene arrested development at the blastocyst stage and pre-
vented the implantation of mouse embryos [26]. This
apparent discrepancy may have different causes. It is pos-
sible that the loss of Ugcg activity is compensated for by
other glycosyltransferase activities expressed during pre-
implantation stages. However, no glycosyltransferase has
been described with such activity yet and no proteins sim-
ilar to the Ugcg enzyme could be retrieved from the
mouse genome so far. Alternatively, it is possible that the
expression of the Ugcg gene in unfertilized oocytes [27]
yields enough of the Ugcg enzyme to sustain the forma-
tion of Glc-Cer until gastrulation.
The enzymatic characterization of the B3gnt5 protein has
shown a significant N-acetylglucosaminyltransferase
activity towards the monosaccharide Gal [7]. Therefore it
is conceivable that B3gnt5 may act on Gal-termini found
on N- or O-linked glycans. However, it is likely that pre-
implantation lethality is in fact mediated by a defect of
GSL biosynthesis, since defects in N- or O-linked glycan
elongations lead to post-implantation lethal phenotypes
at the earliest [28]. Indeed, the inactivation of the B3gnt2
gene, a paralog of B3gnt5 that mediates the formation of
poly-N-acetyllactosamine chains on glycoproteins, does
not impair embryonic development [29].
Even if the pre-implantation lethality observed in the
B3gnt5-null embryos is caused by a defect of GSL biosyn-
thesis, the question remains whether the loss of B3gnt5
solely affects the lactoseries derived GSL pathway. Our
analysis of GSL profiles in ES cells bearing a B3gnt5-null
allele showed decreased levels of additional GSL struc-
tures, such as the gangliosides GM3, GM1, GD1 and the
globosides Gb3, Gb5 (Fig. 5). Earlier work has docu-
mented the physical interaction of glycosyltransferases
involved in GSL biosynthesis [30], suggesting that the loss
of a single enzyme might destabilize the localization and
thereby the activity of other enzymes.
Conclusion
The disruption of the B3gnt5 gene leads to the earliest
lethality reported for a Golgi-localized glycosyltransferase,
thereby underlining the essential role of lactoseries
derived GSL and possibly of protein-bound β3GlcNAc-
linked glycans in pre-implantation embryogenesis.
Because of this early lethality, the role of these glycocon-
jugates in subsequent developmental pathways could not
be determined in the present model. The expression pat-
tern of the B3gnt5 gene at gastrulation and at later stages
would support the involvement of B3gnt5  products in
processes such as neurogenesis and brain development.
The production of a conditional B3gnt5  gene targeting
model will certainly bring new insights on the role of lac-
toseries derived GSL in organ development and functions.
Methods
B3gnt5 gene targeting
The targeting vector was assembled by flanking the PGK-
Neo cassette of the pPGK-Neo plasmid [31] with two frag-
ments of 129Sv/J genomic DNA fragments isolated from
a λFIX-II bacteriophage library (Stratagene). The left arm,
a 1.7-kbp BstXI-NdeI fragment that includes 400 bp of the
B3gnt5 exon 4, was inserted blunt-end into the NotI site of
pPGK-Neo and the right arm of the targeting vector was
subcloned blunt-end as a 3.6-kbp BstXI-XbaI fragment
into the EcoRV site of pPGK-Neo. Using this construct, a
stretch of 745 bp encoding the catalytic domain of B3gnt5
was replaced by the PGK-Neo cassette (Fig. 2A). The tar-
geting vector was linearized at the unique Sac II site and
10 μg were electroporated into 5 × 106 mouse embryonic
stem (ES) cells of line R1 [32] and TC1 [33]. Cells were
seeded on gelatin-coated Petri dishes and cultured in KO
DMEM (Gibco) containing 15% fetal calf serum (Gibco),
1000 U/ml leukemia inhibitory factor (ESGRO, Gibco)
and G418 (200 μg/ml). After 5 days of selection, 300
clones were picked and tested for homologous recombi-
nation by PCR and genomic Southern blotting.
Genotyping of ES cell clones
Homologously recombined B3gnt5 alleles were identified
by PCR amplification of a 1920-bp fragment comprising
the boundary of PGK-Neo up to the genomic DNA proxi-
mal to the left arm of the targeting vector. The PCR reac-
tion was carried out using 50 ng of genomic DNA with the
primers 5'-TACTACCCTGTCTAGGAGCAGTTG-3' and 5'-
CATCGCATTGTCTGAGTAGGTGTC-3' for 35 cycles at
94°C for 45 s, 52°C for 1 min, and 72°C for 2 min.
Homologous recombination at the B3gnt5 locus was con-
firmed by genomic Southern blotting. Genomic DNA (5
μg) samples were digested with EcoRI transferred to
Hybond-N membranes (GE Healthcare) and hybridized
to a 530-bp EcoRI-BstXI genomic fragment (Fig. 2A) as a
probe. The detection of a 2.3-kbp fragment was indicative
of a targeted B3gnt5 allele, whereas the wildtype allele was
detected as a 3.0-kbp fragment.
Generation and breeding of B3gnt5-targeted mice
The homologously recombined ES cell clones were karyo-
typed using the standard potassium chloride method
[34]. ES cell clones harboring 40 chromosomes were
injected into blastocyst-stage embryos. The resulting chi-
meric males were bred at 8 weeks of age with C57BL/6
females and germ-line transmission was observed with
the birth of agouti offspring. Mice harboring the targeted
B3gnt5 allele were backcrossed for five generations to the
C57BL/6 background.
Genotyping of mouse samples
The  B3gnt5-wildtype and -null alleles were detected in
DNA isolated from tail biopsies, from embryonic-day-10BMC Developmental Biology 2008, 8:109 http://www.biomedcentral.com/1471-213X/8/109
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(E10) whole embryos and from blastocyst-stage embryos.
Blastocysts were harvested from time-mated pregnant
females by flushing the uterine horns with M2 buffer
(Sigma). The tissue samples were digested with a 25 μg/ml
proteinase K solution at 56°C for 16 h and the reaction
was stopped by incubation at 95°C for 10 min. The
wildtype allele was detected by PCR using the primers 5'-
GGCTCAAGATGTCCTCCTCTTA-3' and 5'-ACATGGTC-
CTGTGGCAAGATTC-3' that yielded a 651-bp fragment.
The null allele was detected as a 789-bp PCR fragment
using the primers 5'-ACTCGTCAAGAAGGCGATAGAA-3'
and 5'-CGGCCATTGAACAAGATGGATT-3'. These PCR
reactions were both run for 35 cycles at 94°C for 1 min,
60.5°C for 45 s, and 72°C for 1 min. Another PCR proto-
col was applied to detect the B3gnt5-null allele in blasto-
cysts. The primers 5'-CATCAGCCGCTACAGTCAAC-3'
and 5'-CATCAGAGCAGCCGATTGTC-3' yielded a 326-bp
fragment corresponding to a fragment of the PGK-Neo
cassette. The corresponding PCR conditions were 35
cycles at 94°C for 45 s, 63.5°C for 40 sec, and 72°C for 40
s.
Glycosyltransferase activity assays
N-acetylglucosaminyltransferase activity was assayed in
B3gnt5-targeted ES cells as described previously [7]. ES
cells (1 × 107) were released by trypsin digest, washed in
PBS twice and lyzed in 200 μl of 2% Triton X-100 in 50
mM cacodylate buffer, pH 7.0, 20 mM MnCl2 for 15 min
on ice in presence of a protease-inhibitor cocktail (Com-
plete EDTA-free, Roche). Reactions were run at 37°C for 4
h using 25 μl of post-nuclear supernatant in 50 μl reac-
tions of 50 mM cacodylate buffer, pH 7.0, 20 mM MnCl2,
5% Me2SO, 0.75 mM ATP, 0.5 mM UDP-GlcNAc includ-
ing 5 × 104 cpm of UDP- [14C]GlcNAc (GE Healthcare).
Reactions were stopped by adding 500 μl ice-cold H2O.
The reaction products were purified by C18 SepPak car-
tridges (Waters) and measured by scintillation counting
[35].
Isolation of pre-implantation embryos
Pre-implantation embryos were obtained from superovu-
lated females. Superovulation was carried out by intra-
peritoneal administration of 50 IU pregnant mare serum
gonadotropin (PMSG) (Intervet, Veterinaria AG Zürich,
Switzerland) and 25 IU human chorionic gonadotropin
(hCG) (Intervet) 48 h later [36]. Embryos were removed
at E1.5 (2–4-cell stage) and E3.5 (blastocyst stage). To
obtain embryos at the 4-cell up to the morula stage, 2-cell
embryos were cultivated in M16 media (Sigma) until the
desired stage was reached. E3.5 blastocysts were isolated
by flushing of the uterine horn.
In Situ Hybridization
Embryos were fixed for 1 h at room temperature in 4%
paraformaldehyde in PBS and washed twice in PBS/0.1%
Tween (PBT) and dehydrated once in 25%, 50%, 75% and
twice in 100% methanol/PBT. The dehydration was fol-
lowed by rehydration in the reverse order of the MeOH/
PBT series 75%, 50%, 25% for 5 min each. The embryos
were permeabilized in RIPA buffer and refixed in 4% PFA/
0.2% glutaraldehyde. Embryos were washed in a 1:1 mix-
ture of PBT/hybridization solution (50% formamide, 5×
SSC, 0.1% Tween-20, 0.1% SDS, 50 μg/ml E. coli tRNA,
60 mM citric acid) for 10 min and then in hybridization
solution. In situ hybridization was performed as described
previously [37]. As a control for the specificity of the labe-
lings in each hybridization experiment, control embryos
were hybridized with an equal concentration of a sense
probe transcribed from the same template as the antisense
probe. After staining over night at 4°C, embryos were post
fixed in 4% paraformaldehyde/0.1% glutaraldehyde in
PBT for 1 h and washed twice in PBT, then cleared in glyc-
erol: PBT (1:1) and stored in glycerol: 2 mM EDTA in PBT
(4:1). Hybridization results were documented using a
Zeiss Axiovert 200 M microscope (Carl Zeiss AG, Feld-
bach, Switzerland). The B3gnt5 908-bp riboprobes were
prepared as described previously [7]. T7 and SP6 ribo-
probes were made using a DIG RNA labeling kit (Roche,
Switzerland) and alkaline hydrolyzed to reduce the size of
the riboprobes to about 300 bp.
Glycosphingolipid analysis
GSL were extracted from mouse ES cells three times with
chloroform:methanol:water (4:8:3, v:v:v) [38]. The
extracts were pooled, dried under N2 and re-dissolved in
chloroform:methanol:PBS (1:163:160, v:v:v). A 1 ml Sep-
Pak tC18 cartridge (Waters) was conditioned with 2 ml
methanol and 2 ml water. The dissolved lipid extract, cor-
responding to 50 mg wet weight of cell pellets were
applied to the SepPak tC18 cartridge, followed by wash-
ing with 3 ml water. GSL were eluted with 1 ml chloro-
form:methanol (98:2, v:v), 2 ml chloroform:methanol
(1:3, v:v) and 1 ml methanol [39]. Eluates were dried
under N2 and subjected to ceramide glycanase digestion,
2-aminobenzamide-labelling and NP-HPLC analysis as
described earlier [40]. One minute fractions were col-
lected from the NP-HPLC and aliquots were subjected
either directly or after desalting with 100 μl custom
packed graphite columns (ENVI-Carb, Supelco) to
MALDI-MS.
Mass Spectrometry
The MALDI matrix was prepared by suspending 10 mg
DHB in 1 ml of 50% acetonitrile, containing 1 mM NaCl.
Sample and matrix were mixed on the MALDI plate at a
ratio of 1:1 and allowed to dry at room temperature. The
dried spots were re-crystallized by applying < 0.1 μl etha-
nol. MALDI mass spectra were recorded in positive ion
mode, using an Applied Biosystems 4800 Proteomics
Analyzer (Applied Biosystems). Averages of 2000 to 5000BMC Developmental Biology 2008, 8:109 http://www.biomedcentral.com/1471-213X/8/109
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laser shots were used to obtain MS/MS spectra. The colli-
sion energy was set at 1 kV and the air pressure inside the
collision cell was set at 2 × 10-6 Torr.
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